About Yuri Deigin

Yuri is a serial entrepreneur, an expert in drug development and venture investments in biotechnology and pharmaceuticals. Yuri brings almost a decade of drug discovery and development experience from his previous role in a biotech startup where he oversaw research and development of original medicines aimed at treating diseases like Alzheimer's and rheumatoid arthritis. Yuri has a track record of not only raising over $20 million for his previous ventures but also initiating and overseeing 4 clinical trials and several pre-clinical studies, including studies in transgenic mice. He also has experience in pharmaceutical product launch, promotion, manufacturing and supply chain management. Since 2013 Yuri also serves as a vice-president of the non-profit Foundation "Science for Life Extension" whose goal is the popularization of the fight against age-related diseases. To further this cause, Yuri frequently blogs, speaks, writes op-ed pieces, and participates in various TV and radio shows. Yuri holds a B.Sc. from the University of Toronto and an M.B.A. from Columbia Business School. Yuri is the CEO of biotech company Youthereum Genetics.
Posts from the author

Today we have an interview with Dr. Aubrey de Grey from the SENS Research Foundation. This interview conducted by Yuri Deigin, CEO at Youthereum Genetics, was originally published in Russian language and he has kindly translated it into English so our audience can enjoy it too. Yuri: Aubrey, thank you very much for agreeing to this…

© 2018 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

       Powered by MMD